Extracorporeal Hyperthermia Perfusion - EHP®

Globally new and unique multimodal hyperthermia therapy procedure

Extracorporeal Hyperthermia-Perfusion - EHP®

New combination therapy method extends the application of hyperthermia

The "Extracorporeal Hyperthermia Perfusion" - EHP® is a globally new and unique multimodal therapy procedure, which we present to the wider public for the first time after several years of research and development.

EHP® combines artificial fever generation (hyperthermia), various types of blood purification (hemoperfusion and apheresis) and increased blood oxygenation (oxyvenation) in a single, completely novel procedure.

EHP®, based on previous findings and patient outcomes, can help to restore the quality of life of chronic disease sufferers in a single step and create a livable future for patients.

EHP - Symbolic illustration

The aim of the EHP® is to free the organism efficiently and as free of side effects as possible from:

  • Tumor cells
  • Borrelia
  • Autoantibodies
  • Viruses, bacteria, fungi
  • Remnants of medicines
  • Heavy metals and toxins

EHP® - a trend-setting, independend methodology for the effective treatment of:

  • Cancers
  • Lyme disease
  • Autoimmune diseases
  • Chronic diseases
  • Sepsis and MRSA
  • Heavy metal pollution and much more

Core components of Extracorporeal Hyperthermia-Perfusion

Learn more about the core components of Extracorporeal Hyperthermia-Perfusion below:


Hyperthermia has been used in conventional medicine for many years, especially in the treatment of cancer in addition to the procedures chemo-therapy, radiotherapy and surgery. It is today considered the "4th pillar" in oncology. But unlike classical hyperthermia, EHP uses the possibility of warming the blood within the whole organism!

Find out more

Note: The page will open in a new window.

Hemoperfusion (Apheresis)

Hemoperfusion is an extracorporeal process that eliminates inflammatory and other harmful molecules from the blood of the human organism. In that way an effective blood purification can be achieved. Numerous drug strategies can be more effective, the metabolism is regulated and the immune system is strengthened.

Find out more

Note: The page will open in a new window.


With the use of an oxyvenator, the hemoperfusion is extended by one more component. This technology comes from cardiac surgery but is also used today in other therapeutic disciplines. The supply of medical oxygen makes it possible to achieve a physical oxygen saturation of more than 700% in the tissue as well.

Find out more

Note: The page will open in a new window.

Indications for the EHP®

The "Extracorporeal Hyperthermia-Perfusion - EHP®" is used singularly or additively in the following conditions and illnesses. Please note that depending on your individual diagnosis, indication and medical history, it may also be the case with the EHP® that the treatment can be repeated several times and combined with other therapies.

The following indications can be treated with the EHP:

  • Astrocytoma
  • Basal Cell Carcinoma
  • Black skin cancer
  • Bladder cancer
  • Bone cancer
  • Brain metastases
  • Breast cancer
  • Cancer of the jaw
  • Colon cancer
  • Endometrial cancer
  • Esophageal cancer
  • Glioblastoma
  • Hodgkin's disease
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymph node cancer
  • Melanoma
  • Non-Hodgkin lymphoma
  • Ovarian cancer
  • Pancreatic cancer
  • Pharyngeal cancer
  • Prostate cancer
  • Rectal cancer
  • Sarcomas
  • Skin cancer
  • Spindle cell carcinoma
  • Stomach cancer
  • Stromal tumors
  • Testicular cancer
  • Uterine cancer
  • Vulvar cancer
  • Achalasia
  • Ankylosing spondylitis
  • Celiac disease
  • Crohn's disease
  • Dermatomyositis
  • Graves' disease
  • Hashimoto's thyroiditis
  • Lambert-Eaton syndrome
  • Lichen sclerosus
  • Lupus erythematosus
  • Multiple sclerosis
  • Myasthenia gravis
  • Psoriasis
  • Reiter's disease
  • Rheumatoid arthritis
  • Rosacea
  • Rheumatoide Arthritis
  • Rosacea
  • Sarcoidosis
  • Type 1 diabetes
  • Wegener's disease
  • Hepatitis B
  • HIV
  • Lyme disease
  • Tuberculosis

Extracorporeal Hyperthermia Perfusion - EHP®

Life-Changing Breakthrough for Your Health

With the development of the EHP®, it has become possible to significantly expand and improve the possibilities of treating many ailments and diseases. It is characterized by maximum efficiency and low side effects or freedom from side effects and often saves patients from having to follow long-term treatment courses over weeks and months.

The EHP® is a pioneering therapy of the future. Initially, we exclusively offer the EHP® in our Center for Advanced Medicine in Frankfurt am Main, Germany, and we are already working on the fact that many colleagues in Germany and abroad can incorporate the EHP® in their service catalog.

Contact us

Would you like to know more about the EHP®? Get in touch.

Your data will of course be treated strictly confidentially.


* required fields

I have read the privacy policy and agree to the purposeful storage of my data.